Abstract: Disclosed is a pharmaceutical composition for the treatment of cognitive symptoms caused by Alzheimer's disease in a mammal. This composition comprising vitamin E, quercitin, caffeic acid, nicotinic acid or derivatives and/or analog thereof, and a pharmaceutically acceptable excipient.
Type:
Application
Filed:
September 4, 2002
Publication date:
August 21, 2003
Applicant:
Colba R & D Inc.
Inventors:
Uri Saragovi, Joseph Bassili, Khassam Elfarrah